                         SEQUENCE LISTING

<110>  PIN Pharma, Inc.
 
<120>  Treatment of Inflammation, Autoimmune, and Neurodegenerative 
       Disorders with HIV Tat Derivative Polypeptides

<130>  1951311-00019

<150>  61/734,135
<151>  2012-12-06

<150>  61/881,66
<151>  2013-09-23

<160>  72    

<170>  PatentIn version 3.5

<210>  1
<211>  303
<212>  DNA
<213>  human immunodeficiency virus

<400>  1
atggagcccg tggaccctcg cctggagccc tggaagcacc cgggcagcca gcccaagacc       60

gcctgcacca catgttactg caagaagtgc tgcttccact gccaggtgtg cttcaccaag      120

aaggccttgg gcatcagcta cggccgcaag aagcgccggc agcgccgccg ggcccctgag      180

gacagccaga cccaccaggt gagccctccc aagcagcccg ctccacagtt ccgcggcgac      240

cctaccggtc ccaaggagag caagaagaag gtggagcgcg agaccgagac ccatcccgtc      300

gac                                                                    303


<210>  2
<211>  101
<212>  PRT
<213>  human immunodeficiency virus

<400>  2

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Thr Lys Lys Ala Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Glu Asp Ser Gln Thr 
    50                  55                  60                  


His Gln Val Ser Pro Pro Lys Gln Pro Ala Pro Gln Phe Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Lys Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu 
                85                  90                  95      


Thr His Pro Val Asp 
            100     


<210>  3
<211>  27
<212>  PRT
<213>  simian immunodeficiency virus

<400>  3

Pro Leu Arg Glu Gln Glu Asn Ser Leu Glu Ser Ser Asn Glu Arg Ser 
1               5                   10                  15      


Ser Cys Ile Leu Glu Ala Asp Ala Thr Thr Pro 
            20                  25          


<210>  4
<211>  11
<212>  PRT
<213>  homo sapiens

<400>  4

Ser Asn Glu Arg Ser Ser Cys Glu Leu Glu Val 
1               5                   10      


<210>  5
<211>  16
<212>  PRT
<213>  human immunodeficiency virus

<400>  5

Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe His Cys Gln Val Cys 
1               5                   10                  15      


<210>  6
<211>  102
<212>  PRT
<213>  artificial sequence

<220>
<223>  Tat derivative polypeptide Nani-P1

<400>  6

Met Glu Pro Val Asp Ala Asn Leu Glu Ala Trp Lys His Ala Gly Ser 
1               5                   10                  15      


Gln Pro Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys 
            20                  25                  30          


Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr 
        35                  40                  45              


Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln 
    50                  55                  60                  


Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly 
65                  70                  75                  80  


Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr 
                85                  90                  95      


Glu Thr Asp Pro Phe Asp 
            100         


<210>  7
<211>  119
<212>  PRT
<213>  artificial sequence

<220>
<223>  Tat derivative polypeptide Nani-P2

<400>  7

Met Asp Pro Lys Gly Glu Glu Asp Gln Asp Val Ser His Gln Asp Leu 
1               5                   10                  15      


Ile Lys Gln Tyr Arg Lys Pro Arg Thr Ala Cys Asn Asn Cys Tyr Cys 
            20                  25                  30          


Lys Lys Cys Cys Phe His Cys Tyr Ala Cys Phe Leu Arg Lys Gly Leu 
        35                  40                  45              


Gly Ile Thr Tyr His Ala Phe Arg Thr Arg Arg Lys Lys Ile Ala Ser 
    50                  55                  60                  


Ala Asp Arg Ile Pro Val Pro Gln Gln Ser Ile Ser Ile Arg Gly Arg 
65                  70                  75                  80  


Asp Ser Gln Thr Thr Gln Glu Ser Gln Lys Lys Val Glu Glu Gln Ala 
                85                  90                  95      


Lys Ala Asn Leu Arg Ile Ser Arg Lys Asn Leu Gly Asp Glu Thr Arg 
            100                 105                 110         


Gly Pro Val Gly Ala Gly Asn 
        115                 


<210>  8
<211>  130
<212>  PRT
<213>  artificial sequence

<220>
<223>  Tat derivative polypeptide Nani-P3

<400>  8

Met Glu Thr Pro Leu Lys Glu Gln Glu Asn Ser Leu Glu Ser Cys Arg 
1               5                   10                  15      


Glu His Ser Ser Ser Ile Ser Glu Val Asp Val Pro Thr Pro Val Ser 
            20                  25                  30          


Cys Leu Arg Lys Gly Gly Arg Cys Trp Asn Arg Cys Ile Gly Asn Thr 
        35                  40                  45              


Arg Gln Ile Gly Ser Cys Gly Val Pro Phe Leu Lys Cys Cys Lys Arg 
    50                  55                  60                  


Lys Pro Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys 
65                  70                  75                  80  


Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr His Gln Ala 
                85                  90                  95      


Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly Asp Pro Thr Gly 
            100                 105                 110         


Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu Thr Asp Pro 
        115                 120                 125             


Phe Asp 
    130 


<210>  9
<211>  101
<212>  PRT
<213>  artificial sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  9

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr 
            20                  25                  30          


His Cys Leu Val Cys Phe Gln Lys Lys Gly Leu Gly Ile Ser His Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Ser Ala Pro Pro Ser Ser Glu Asp 
    50                  55                  60                  


His Gln Asn Leu Ile Ser Lys Gln Pro Ile Pro Arg Thr Gln Gly Asp 
65                  70                  75                  80  


Gln Thr Gly Ser Glu Glu Ser Lys Lys Lys Val Glu Ser Lys Thr Glu 
                85                  90                  95      


Thr Asp Pro Phe Asp 
            100     


<210>  10
<211>  101
<212>  PRT
<213>  artificial sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  10

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Thr Thr Ala Cys Ser Lys Cys Tyr Cys Lys Ile Cys Cys 
            20                  25                  30          


Trp His Cys Gln Leu Cys Leu Lys Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr 
    50                  55                  60                  


His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu 
                85                  90                  95      


Thr Asp Pro Phe Asp 
            100     


<210>  11
<211>  109
<212>  PRT
<213>  artificial sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  11

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr 
    50                  55                  60                  


His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu 
                85                  90                  95      


Thr Asp Pro Phe Asp Asp Glu Cys Glu Met Asx Glu Arg 
            100                 105                 


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Repeat sequence for Tat derivative peptide TF region

<400>  12

Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser Gln Pro 
1               5                   10                  15      


<210>  13
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  13

Met Asp Pro Thr Asp Pro Glu Leu Pro Pro Trp Gln Gln Pro Gly Ser 
1               5                   10                  15      


Gln Pro Pro Thr Pro Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys 
            20                  25                  30          


Lys Cys Cys Phe His Cys Gln Val Cys Phe Leu Gln Lys Gly Leu Gly 
        35                  40                  45              


Ile Thr Tyr Ala Arg Pro Arg Lys Arg Ala Ala Arg Ser Ile Ser Glu 
    50                  55                  60                  


Asp Asp Ser Ala Pro Thr Glu Pro Tyr Pro Gly Pro Glu Gly Pro Arg 
65                  70                  75                  80  


Gln Thr Arg Arg Arg Arg Arg Arg Gln Trp Arg Gln Arg Arg Thr Gln 
                85                  90                  95      


Arg Leu Tyr Leu Gln Gln Arg Ile Phe Glu Ala Ile Phe Gly Ser Arg 
            100                 105                 110         


Thr Ala Ala Leu Glu Asp Ser Leu Gln Gln Leu Gln Ile Ser Asp 
        115                 120                 125         


<210>  14
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  14

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr 
            20                  25                  30          


His Cys Leu Val Cys Phe Leu Gln Lys Gly Leu Gly Ile Thr Tyr Ala 
        35                  40                  45              


Arg Pro Arg Lys Arg Ala Ala Arg Ser Ile Ser Glu Asp Asp Ser Ala 
    50                  55                  60                  


Pro Thr Glu Pro Tyr Pro Gly Pro Glu Gly Pro Arg Gln Thr Arg Arg 
65                  70                  75                  80  


Arg Arg Arg Arg Gln Trp Arg Gln Arg Arg Thr Gln Arg Leu Tyr Leu 
                85                  90                  95      


Gln Gln Arg Ile Phe Glu Ala Ile Phe Gly Ser Arg Thr Ala Ala Leu 
            100                 105                 110         


Glu Asp Ser Leu Gln Gln Leu Gln Ile Ser Asp 
        115                 120             


<210>  15
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  15

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Ala Cys Tyr Cys Arg Ile Pro Ala Cys Ile Ala Gly Glu Arg 
            20                  25                  30          


Arg Tyr Gly Thr Cys Ile Tyr Gln Gly Arg Leu Trp Ala Phe Cys Cys 
        35                  40                  45              


Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr 
    50                  55                  60                  


Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln 
65                  70                  75                  80  


Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly 
                85                  90                  95      


Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr 
            100                 105                 110         


Glu Thr Asp Pro Phe Asp 
        115             


<210>  16
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  16

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Gly Ile Gly Asp Pro Val Thr Cys Leu Lys Ser Gly Ala Ile 
            20                  25                  30          


Cys His Pro Val Phe Cys Pro Arg Arg Tyr Lys Gln Ile Gly Thr Cys 
        35                  40                  45              


Gly Leu Pro Gly Thr Lys Cys Cys Lys Lys Pro Phe His Cys Gln Val 
    50                  55                  60                  


Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys Arg 
65                  70                  75                  80  


Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr His Gln Ala Ser 
                85                  90                  95      


Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly Asp Pro Thr Gly Pro 
            100                 105                 110         


Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu Thr Asp Pro Phe 
        115                 120                 125             


Asp 
    


<210>  17
<211>  82
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  17

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Asn Asn Cys His Cys Lys Val Cys Cys Tyr 
            20                  25                  30          


His Cys Val Tyr Cys Phe Thr Lys Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Arg Pro Ala Arg Thr Ala Asp Lys Asp Gln Asp 
    50                  55                  60                  


Asn Gln Asp Pro Val Ser Lys Gln Ser Leu Ala Gly Thr Arg Ser Gln 
65                  70                  75                  80  


Gln Glu 
        


<210>  18
<211>  100
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  18

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Thr Thr Ala Cys Ser Lys Cys Tyr Cys Lys Ile Cys Cys Trp 
            20                  25                  30          


His Cys Gln Leu Cys Leu Lys Lys Gly Leu Gly Ile Ser Tyr Gly Arg 
        35                  40                  45              


Lys Lys Arg Lys His Arg Arg Gly Thr Pro Gln Ser Ser Lys Asp His 
    50                  55                  60                  


Gln Asn Pro Ile Pro Glu Gln Pro Leu Pro Ile Ile Arg Gly Asn Pro 
65                  70                  75                  80  


Thr Asp Pro Lys Glu Ser Lys Lys Glu Val Ala Ser Lys Ala Glu Thr 
                85                  90                  95      


Asp Pro Phe Asp 
            100 


<210>  19
<211>  102
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  19

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser 
            20                  25                  30          


Tyr His Cys Leu Val Cys Phe Gln Lys Lys Gly Leu Gly Ile Ser His 
        35                  40                  45              


Gly Arg Lys Lys Arg Arg Gln Arg Arg Ser Ala Pro Pro Ser Ser Glu 
    50                  55                  60                  


Asp His Gln Asn Leu Ile Ser Lys Gln Pro Ile Pro Arg Thr Gln Gly 
65                  70                  75                  80  


Asp Gln Thr Gly Ser Glu Glu Ser Lys Lys Lys Val Glu Ser Lys Thr 
                85                  90                  95      


Glu Thr Asp Pro Phe Asp 
            100         


<210>  20
<211>  99
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  20

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Thr Thr Ala Cys Ser Lys Cys Tyr Cys Lys Ile Cys Cys Trp His 
            20                  25                  30          


Cys Gln Leu Cys Leu Lys Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys 
        35                  40                  45              


Lys Arg Lys His Arg Arg Gly Thr Pro Gln Ser Ser Lys Asp His Gln 
    50                  55                  60                  


Asn Pro Ile Pro Glu Gln Pro Leu Pro Ile Ile Arg Gly Asn Pro Thr 
65                  70                  75                  80  


Asp Pro Lys Glu Ser Lys Lys Glu Val Ala Ser Lys Ala Glu Thr Asp 
                85                  90                  95      


Pro Phe Asp 
            


<210>  21
<211>  100
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  21

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr His 
            20                  25                  30          


Cys Leu Val Cys Phe Gln Lys Lys Gly Leu Gly Ile Ser His Gly Arg 
        35                  40                  45              


Lys Lys Arg Arg Gln Arg Arg Ser Ala Pro Pro Ser Ser Glu Asp His 
    50                  55                  60                  


Gln Asn Leu Ile Ser Lys Gln Pro Ile Pro Arg Thr Gln Gly Asp Gln 
65                  70                  75                  80  


Thr Gly Ser Glu Glu Ser Lys Lys Lys Val Glu Ser Lys Thr Glu Thr 
                85                  90                  95      


Asp Pro Phe Asp 
            100 


<210>  22
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  22

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Arg Thr Cys His Cys Arg Ser Arg Cys Leu Arg Arg Glu 
            20                  25                  30          


Ser Asn Ser Gly Ser Cys Asn Ile Asn Gly Arg Ile Ser Ser Leu Cys 
        35                  40                  45              


Cys Phe Leu Lys Lys Gly Leu Gly Ile Ser Tyr Glu Lys Ser His Arg 
    50                  55                  60                  


Arg Arg Arg Thr Pro Lys Lys Ala Lys Ala Asn Thr Ser Ser Ala Ser 
65                  70                  75                  80  


Asn Glu Pro Ile Pro Asn Arg Ile Arg Leu Cys Gln Pro Lys Lys Ala 
                85                  90                  95      


Lys Lys Glu Thr Val Glu Ala Ala Val Ala Thr Ala Pro Gly Leu Gly 
            100                 105                 110         


Arg 
    


<210>  23
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  23

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Arg Thr Cys His Cys Arg Ser Arg Cys Leu Arg Arg Glu Ser Asn 
            20                  25                  30          


Ser Gly Ser Cys Asn Ile Asn Gly Arg Ile Ser Ser Leu Cys Cys Phe 
        35                  40                  45              


Leu Lys Lys Gly Leu Gly Ile Ser Tyr Glu Lys Ser His Arg Arg Arg 
    50                  55                  60                  


Arg Thr Pro Lys Lys Ala Lys Ala Asn Thr Ser Ser Ala Ser Asn Glu 
65                  70                  75                  80  


Pro Ile Pro Asn Arg Ile Arg Leu Cys Gln Pro Lys Lys Ala Lys Lys 
                85                  90                  95      


Glu Thr Val Glu Ala Ala Val Ala Thr Ala Pro Gly Leu Gly Arg 
            100                 105                 110     


<210>  24
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  24

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Arg Thr Cys His Cys Arg Ser Arg Cys Leu Arg Arg Glu Ser 
            20                  25                  30          


Asn Ser Gly Ser Cys Asn Ile Asn Gly Arg Ile Ser Ser Leu Cys Cys 
        35                  40                  45              


Phe Leu Lys Lys Gly Leu Gly Ile Ser Tyr Glu Lys Ser His Arg Arg 
    50                  55                  60                  


Arg Arg Thr Pro Lys Lys Ala Lys Ala Asn Thr Ser Ser Ala Ser Asn 
65                  70                  75                  80  


Glu Pro Ile Pro Asn Arg Ile Arg Leu Cys Gln Pro Lys Lys Ala Lys 
                85                  90                  95      


Lys Glu Thr Val Glu Ala Ala Val Ala Thr Ala Pro Gly Leu Gly Arg 
            100                 105                 110         


<210>  25
<211>  101
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  25

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys 
            20                  25                  30          


Cys Tyr His Cys Gln His Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys 
        35                  40                  45              


Tyr Glu Gln Gln Arg Arg Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr 
    50                  55                  60                  


Ser Ser Ala Ser Asp Lys Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln 
65                  70                  75                  80  


Pro Lys Lys Glu Lys Lys Glu Thr Val Glu Ala Glu Val Ala Thr Asp 
                85                  90                  95      


Leu Gly Leu Gly Arg 
            100     


<210>  26
<211>  99
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  26

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys Cys Tyr 
            20                  25                  30          


His Cys Gln His Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr Glu 
        35                  40                  45              


Gln Gln Arg Arg Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser Ser 
    50                  55                  60                  


Ala Ser Asp Lys Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro Lys 
65                  70                  75                  80  


Lys Glu Lys Lys Glu Thr Val Glu Ala Glu Val Ala Thr Asp Leu Gly 
                85                  90                  95      


Leu Gly Arg 
            


<210>  27
<211>  100
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  27

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys Cys 
            20                  25                  30          


Tyr His Cys Gln His Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr 
        35                  40                  45              


Glu Gln Gln Arg Arg Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser 
    50                  55                  60                  


Ser Ala Ser Asp Lys Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro 
65                  70                  75                  80  


Lys Lys Glu Lys Lys Glu Thr Val Glu Ala Glu Val Ala Thr Asp Leu 
                85                  90                  95      


Gly Leu Gly Arg 
            100 


<210>  28
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  28

Met Met Glu Pro Val Asp Pro Asp Leu Pro Lys Glu Gln His Pro Pro 
1               5                   10                  15      


Ala Thr Pro Arg Cys Glu Ser Cys Lys Leu Gly Arg Gly Arg Cys Arg 
            20                  25                  30          


Lys Glu Cys Leu Glu Asn Glu Lys Pro Asp Gly Arg Cys Arg Leu Asn 
        35                  40                  45              


Phe Leu Cys Cys Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu 
    50                  55                  60                  


Gly Ile Ser Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro 
65                  70                  75                  80  


Gln Asp Ser Gln Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser 
                85                  90                  95      


Gln Ser Arg Gly Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val 
            100                 105                 110         


Glu Arg Glu Thr Glu Thr Asp Pro Phe Asp 
        115                 120         


<210>  29
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  29

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Cys Glu Ser Cys Lys Leu Gly Arg Gly Arg Cys Arg Lys 
            20                  25                  30          


Glu Cys Leu Glu Asn Glu Lys Pro Asp Gly Arg Cys Arg Leu Asn Phe 
        35                  40                  45              


Leu Cys Cys Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly 
    50                  55                  60                  


Ile Ser Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln 
65                  70                  75                  80  


Asp Ser Gln Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln 
                85                  90                  95      


Ser Arg Gly Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu 
            100                 105                 110         


Arg Glu Thr Glu Thr Asp Pro Phe Asp 
        115                 120     


<210>  30
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  30

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Cys Glu Ser Cys Lys Leu Gly Arg Gly Arg Cys Arg Lys Glu 
            20                  25                  30          


Cys Leu Glu Asn Glu Lys Pro Asp Gly Arg Cys Arg Leu Asn Phe Leu 
        35                  40                  45              


Cys Cys Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile 
    50                  55                  60                  


Ser Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp 
65                  70                  75                  80  


Ser Gln Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser 
                85                  90                  95      


Arg Gly Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg 
            100                 105                 110         


Glu Thr Glu Thr Asp Pro Phe Asp 
        115                 120 


<210>  31
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  31

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Cys Glu Ser Cys Lys Leu Gly Arg Gly Arg Cys Arg Lys Glu Cys 
            20                  25                  30          


Leu Glu Asn Glu Lys Pro Asp Gly Arg Cys Arg Leu Asn Phe Leu Cys 
        35                  40                  45              


Cys Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser 
    50                  55                  60                  


Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser 
65                  70                  75                  80  


Gln Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg 
                85                  90                  95      


Gly Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu 
            100                 105                 110         


Thr Glu Thr Asp Pro Phe Asp 
        115                 


<210>  32
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  32

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Pro Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro 
            20                  25                  30          


Gly Ser Gln Pro Lys Thr Ala Cys Asn Asn Cys His Cys Lys Val Cys 
        35                  40                  45              


Cys Tyr His Cys Val Tyr Cys Phe Phe His Cys Gln Val Cys Phe Thr 
    50                  55                  60                  


Arg Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys Arg Arg Gln Arg 
65                  70                  75                  80  


Arg Arg Ala Pro Gln Asp Ser Gln Thr His Gln Ala Ser Leu Ser Lys 
                85                  90                  95      


Gln Pro Ala Ser Gln Ser Arg Gly Asp Pro Thr Gly Pro Thr Glu Ser 
            100                 105                 110         


Lys Lys Lys Val Glu Arg Glu Thr Glu Thr Asp Pro Phe Asp 
        115                 120                 125     


<210>  33
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  33

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Leu Arg Cys Ile Cys Arg Arg Gly Ile Cys Arg Leu Leu 
            20                  25                  30          


Gln Arg Arg Tyr Gly Ser Cys Ala Phe Pro Gly Arg Leu Tyr Arg Ile 
        35                  40                  45              


Cys Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr Glu Gln Gln Arg 
    50                  55                  60                  


Arg Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser Ser Ala Ser Asp 
65                  70                  75                  80  


Lys Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro Lys Lys Glu Lys 
                85                  90                  95      


Lys Glu Thr Val Glu Ala Glu Val Ala Thr Asp Leu Gly Leu Gly Arg 
            100                 105                 110         


<210>  34
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  34

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro Leu Arg Cys Ile Cys Arg Arg Gly Ile Cys Arg Leu Leu Gln Arg 
            20                  25                  30          


Arg Tyr Gly Ser Cys Ala Phe Pro Gly Arg Leu Tyr Arg Ile Cys Cys 
        35                  40                  45              


Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr Glu Gln Gln Arg Arg Arg 
    50                  55                  60                  


Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser Ser Ala Ser Asp Lys Ser 
65                  70                  75                  80  


Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro Lys Lys Glu Lys Lys Glu 
                85                  90                  95      


Thr Val Glu Ala Glu Val Ala Thr Asp Leu Gly Leu Gly Arg 
            100                 105                 110 


<210>  35
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  35

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Leu Arg Cys Ile Cys Arg Arg Gly Ile Cys Arg Leu Leu Gln 
            20                  25                  30          


Arg Arg Tyr Gly Ser Cys Ala Phe Pro Gly Arg Leu Tyr Arg Ile Cys 
        35                  40                  45              


Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr Glu Gln Gln Arg Arg 
    50                  55                  60                  


Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser Ser Ala Ser Asp Lys 
65                  70                  75                  80  


Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro Lys Lys Glu Lys Lys 
                85                  90                  95      


Glu Thr Val Glu Ala Glu Val Ala Thr Asp Leu Gly Leu Gly Arg 
            100                 105                 110     


<210>  36
<211>  21
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  36

Met Asp Pro Thr Asp Pro Glu Leu Pro Pro Trp Gln Gln Pro Gly Ser 
1               5                   10                  15      


Gln Pro Pro Thr Pro 
            20      


<210>  37
<211>  21
<212>  PRT
<213>  Human immunodeficiency virus

<400>  37

Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe His 
1               5                   10                  15      


Cys Gln Val Cys Phe 
            20      


<210>  38
<211>  85
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  38

Leu Gln Lys Gly Leu Gly Ile Thr Tyr Ala Arg Pro Arg Lys Arg Ala 
1               5                   10                  15      


Ala Arg Ser Ile Ser Glu Asp Asp Ser Ala Pro Thr Glu Pro Tyr Pro 
            20                  25                  30          


Gly Pro Glu Gly Pro Arg Gln Thr Arg Arg Arg Arg Arg Arg Gln Trp 
        35                  40                  45              


Arg Gln Arg Arg Thr Gln Arg Leu Tyr Leu Gln Gln Arg Ile Phe Glu 
    50                  55                  60                  


Ala Ile Phe Gly Ser Arg Thr Ala Ala Leu Glu Asp Ser Leu Gln Gln 
65                  70                  75                  80  


Leu Gln Ile Ser Asp 
                85  


<210>  39
<211>  18
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  39

Met Asp Pro Ile Asp Pro Asp Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro 
        


<210>  40
<211>  20
<212>  PRT
<213>  human immunodeficiency virus

<400>  40

Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr His Cys 
1               5                   10                  15      


Leu Val Cys Phe 
            20  


<210>  41
<211>  30
<212>  PRT
<213>  homo sapiens

<400>  41

Ala Cys Tyr Cys Arg Ile Pro Ala Cys Ile Ala Gly Glu Arg Arg Tyr 
1               5                   10                  15      


Gly Thr Cys Ile Tyr Gln Gly Arg Leu Trp Ala Phe Cys Cys 
            20                  25                  30  


<210>  42
<211>  70
<212>  PRT
<213>  human immunodeficiency virus

<400>  42

Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr 
1               5                   10                  15      


Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln 
            20                  25                  30          


Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly 
        35                  40                  45              


Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr 
    50                  55                  60                  


Glu Thr Asp Pro Phe Asp 
65                  70  


<210>  43
<211>  41
<212>  PRT
<213>  homo sapiens

<400>  43

Gly Ile Gly Asp Pro Val Thr Cys Leu Lys Ser Gly Ala Ile Cys His 
1               5                   10                  15      


Pro Val Phe Cys Pro Arg Arg Tyr Lys Gln Ile Gly Thr Cys Gly Leu 
            20                  25                  30          


Pro Gly Thr Lys Cys Cys Lys Lys Pro 
        35                  40      


<210>  44
<211>  18
<212>  PRT
<213>  human immunodeficiency virus

<400>  44

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro 
        


<210>  45
<211>  20
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  45

Lys Thr Ala Cys Asn Asn Cys His Cys Lys Val Cys Cys Tyr His Cys 
1               5                   10                  15      


Val Tyr Cys Phe 
            20  


<210>  46
<211>  44
<212>  PRT
<213>  simian immunodeficiency virus

<400>  46

Thr Lys Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys Arg Arg Arg 
1               5                   10                  15      


Pro Ala Arg Thr Ala Asp Lys Asp Gln Asp Asn Gln Asp Pro Val Ser 
            20                  25                  30          


Lys Gln Ser Leu Ala Gly Thr Arg Ser Gln Gln Glu 
        35                  40                  


<210>  47
<211>  82
<212>  PRT
<213>  human immunodeficiency virus

<400>  47

Thr Thr Ala Cys Ser Lys Cys Tyr Cys Lys Ile Cys Cys Trp His Cys 
1               5                   10                  15      


Gln Leu Cys Leu Lys Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys 
            20                  25                  30          


Arg Lys His Arg Arg Gly Thr Pro Gln Ser Ser Lys Asp His Gln Asn 
        35                  40                  45              


Pro Ile Pro Glu Gln Pro Leu Pro Ile Ile Arg Gly Asn Pro Thr Asp 
    50                  55                  60                  


Pro Lys Glu Ser Lys Lys Glu Val Ala Ser Lys Ala Glu Thr Asp Pro 
65                  70                  75                  80  


Phe Asp 
        


<210>  48
<211>  19
<212>  PRT
<213>  homo sapiens

<400>  48

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro 
            


<210>  49
<211>  83
<212>  PRT
<213>  Human immunodeficiency virus

<400>  49

Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr His Cys 
1               5                   10                  15      


Leu Val Cys Phe Gln Lys Lys Gly Leu Gly Ile Ser His Gly Arg Lys 
            20                  25                  30          


Lys Arg Arg Gln Arg Arg Ser Ala Pro Pro Ser Ser Glu Asp His Gln 
        35                  40                  45              


Asn Leu Ile Ser Lys Gln Pro Ile Pro Arg Thr Gln Gly Asp Gln Thr 
    50                  55                  60                  


Gly Ser Glu Glu Ser Lys Lys Lys Val Glu Ser Lys Thr Glu Thr Asp 
65                  70                  75                  80  


Pro Phe Asp 
            


<210>  50
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  immunosuppressive artificial sequence

<400>  50

Met Ala Gly Pro His Pro Val Ile Val Ile Thr Gly Pro His Glu Glu 
1               5                   10                  15      


Pro 
    


<210>  51
<211>  30
<212>  PRT
<213>  Macaca mulatta

<400>  51

Arg Thr Cys His Cys Arg Ser Arg Cys Leu Arg Arg Glu Ser Asn Ser 
1               5                   10                  15      


Gly Ser Cys Asn Ile Asn Gly Arg Ile Ser Ser Leu Cys Cys 
            20                  25                  30  


<210>  52
<211>  64
<212>  PRT
<213>  simian immunodeficiency virus

<400>  52

Phe Leu Lys Lys Gly Leu Gly Ile Ser Tyr Glu Lys Ser His Arg Arg 
1               5                   10                  15      


Arg Arg Thr Pro Lys Lys Ala Lys Ala Asn Thr Ser Ser Ala Ser Asn 
            20                  25                  30          


Glu Pro Ile Pro Asn Arg Ile Arg Leu Cys Gln Pro Lys Lys Ala Lys 
        35                  40                  45              


Lys Glu Thr Val Glu Ala Ala Val Ala Thr Ala Pro Gly Leu Gly Arg 
    50                  55                  60                  


<210>  53
<211>  82
<212>  PRT
<213>  simian immunodeficiency virus

<400>  53

Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys Cys Tyr His 
1               5                   10                  15      


Cys Gln His Cys Phe Leu Lys Lys Gly Leu Gly Ile Cys Tyr Glu Gln 
            20                  25                  30          


Gln Arg Arg Arg Thr Pro Lys Lys Thr Lys Ala Asn Thr Ser Ser Ala 
        35                  40                  45              


Ser Asp Lys Ser Leu Ser Arg Arg Ala Arg Asn Cys Gln Pro Lys Lys 
    50                  55                  60                  


Glu Lys Lys Glu Thr Val Glu Ala Glu Val Ala Thr Asp Leu Gly Leu 
65                  70                  75                  80  


Gly Arg 
        


<210>  54
<211>  20
<212>  PRT
<213>  simian immunodeficiency virus

<400>  54

Met Met Glu Pro Val Asp Pro Asp Leu Pro Lys Glu Gln His Pro Pro 
1               5                   10                  15      


Ala Thr Pro Arg 
            20  


<210>  55
<211>  32
<212>  PRT
<213>  Chlorocebus aethiops

<400>  55

Cys Glu Ser Cys Lys Leu Gly Arg Gly Arg Cys Arg Lys Glu Cys Leu 
1               5                   10                  15      


Glu Asn Glu Lys Pro Asp Gly Arg Cys Arg Leu Asn Phe Leu Cys Cys 
            20                  25                  30          


<210>  56
<211>  36
<212>  PRT
<213>  Human immunodeficiency virus

<400>  56

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Pro Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro 
            20                  25                  30          


Gly Ser Gln Pro 
        35      


<210>  57
<211>  20
<212>  PRT
<213>  simian immunodeficiency virus

<400>  57

Lys Thr Ala Cys Asn Asn Cys His Cys Lys Val Cys Cys Tyr His Cys 
1               5                   10                  15      


Val Tyr Cys Phe 
            20  


<210>  58
<211>  31
<212>  PRT
<213>  pongo abelli

<400>  58

Leu Arg Cys Ile Cys Arg Arg Gly Ile Cys Arg Leu Leu Gln Arg Arg 
1               5                   10                  15      


Tyr Gly Ser Cys Ala Phe Pro Gly Arg Leu Tyr Arg Ile Cys Cys 
            20                  25                  30      


<210>  59
<211>  18
<212>  PRT
<213>  Human immunodeficiency virus

<400>  59

Met Glu Pro Val Asp Ala Asn Leu Glu Ala Trp Lys His Ala Gly Ser 
1               5                   10                  15      


Gln Pro 
        


<210>  60
<211>  23
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  60

Met Asp Pro Lys Gly Glu Glu Asp Gln Asp Val Ser His Gln Asp Leu 
1               5                   10                  15      


Ile Lys Gln Tyr Arg Lys Pro 
            20              


<210>  61
<211>  30
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  61

Met Glu Thr Pro Leu Lys Glu Gln Glu Asn Ser Leu Glu Ser Cys Arg 
1               5                   10                  15      


Glu His Ser Ser Ser Ile Ser Glu Val Asp Val Pro Thr Pro 
            20                  25                  30  


<210>  62
<211>  31
<212>  PRT
<213>  Human immunodeficiency virus

<400>  62

Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe His 
1               5                   10                  15      


Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
            20                  25                  30      


<210>  63
<211>  35
<212>  PRT
<213>  Human immunodeficiency virus

<400>  63

Arg Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe His Cys 
1               5                   10                  15      


Tyr Ala Cys Phe Leu Arg Lys Gly Leu Gly Ile Thr Tyr His Ala Phe 
            20                  25                  30          


Arg Thr Arg 
        35  


<210>  64
<211>  47
<212>  PRT
<213>  Mus musculus

<400>  64

Val Ser Cys Leu Arg Lys Gly Gly Arg Cys Trp Asn Arg Cys Ile Gly 
1               5                   10                  15      


Asn Thr Arg Gln Ile Gly Ser Cys Gly Val Pro Phe Leu Lys Cys Cys 
            20                  25                  30          


Lys Arg Lys Pro Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45          


<210>  65
<211>  30
<212>  PRT
<213>  Human immunodeficiency virus

<400>  65

Glu Thr Ala Cys Asn Asn Cys Phe Cys Lys Lys Cys Ser Tyr His Cys 
1               5                   10                  15      


Leu Val Cys Phe Gln Lys Lys Gly Leu Gly Ile Ser His Gly 
            20                  25                  30  


<210>  66
<211>  29
<212>  PRT
<213>  Human immunodeficiency virus

<400>  66

Thr Thr Ala Cys Ser Lys Cys Tyr Cys Lys Ile Cys Cys Trp His Cys 
1               5                   10                  15      


Gln Leu Cys Leu Lys Lys Gly Leu Gly Ile Ser Tyr Gly 
            20                  25                  


<210>  67
<211>  31
<212>  PRT
<213>  Human immunodeficiency virus

<400>  67

Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe His 
1               5                   10                  15      


Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
            20                  25                  30      


<210>  68
<211>  61
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  68

Arg Lys Lys Ile Ala Ser Ala Asp Arg Ile Pro Val Pro Gln Gln Ser 
1               5                   10                  15      


Ile Ser Ile Arg Gly Arg Asp Ser Gln Thr Thr Gln Glu Ser Gln Lys 
            20                  25                  30          


Lys Val Glu Glu Gln Ala Lys Ala Asn Leu Arg Ile Ser Arg Lys Asn 
        35                  40                  45              


Leu Gly Asp Glu Thr Arg Gly Pro Val Gly Ala Gly Asn 
    50                  55                  60      


<210>  69
<211>  103
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunosuppressive Tat derivative polypeptide

<400>  69

Met Glu Pro Leu Thr Pro His Pro Trp Val Tyr Ser Gly Gly Gln Pro 
1               5                   10                  15      


Lys Val Pro Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys 
            20                  25                  30          


Cys Tyr His Cys Gln His Cys Phe Ser Lys Lys Gly Leu Gly Ile Ser 
        35                  40                  45              


Tyr Glu Arg Lys Gly Arg Arg Arg Arg Thr Pro Arg Lys Thr Lys Thr 
    50                  55                  60                  


Pro Ser Pro Ser Ala Pro Asp Lys Ser Ile Ser Thr Arg Thr Gly Asp 
65                  70                  75                  80  


Ser Gln Pro Thr Lys Glu Gln Lys Lys Thr Ser Glu Ala Thr Val Val 
                85                  90                  95      


Thr Thr Cys Gly Leu Gly Gln 
            100             


<210>  70
<211>  21
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  70

Leu Glu Ala Cys Tyr Asn Lys Cys Tyr Cys Lys Arg Cys Cys Tyr His 
1               5                   10                  15      


Cys Gln His Cys Phe 
            20      


<210>  71
<211>  63
<212>  PRT
<213>  Human immunodeficiency virus

<400>  71

Ser Lys Lys Gly Leu Gly Ile Ser Tyr Glu Arg Lys Gly Arg Arg Arg 
1               5                   10                  15      


Arg Thr Pro Arg Lys Thr Lys Thr Pro Ser Pro Ser Ala Pro Asp Lys 
            20                  25                  30          


Ser Ile Ser Thr Arg Thr Gly Asp Ser Gln Pro Thr Lys Glu Gln Lys 
        35                  40                  45              


Lys Thr Ser Glu Ala Thr Val Val Thr Thr Cys Gly Leu Gly Gln 
    50                  55                  60              


<210>  72
<211>  127
<212>  PRT
<213>  Mus musculus

<400>  72

Met Asp Pro Thr Asp Pro Glu Leu Pro Pro Trp Gln Gln Pro Gly Ser 
1               5                   10                  15      


Gln Pro Pro Thr Pro Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys 
            20                  25                  30          


Lys Cys Cys Phe His Cys Gln Val Cys Phe Leu Gln Lys Gly Leu Gly 
        35                  40                  45              


Ile Thr Tyr Ala Arg Pro Arg Lys Arg Ala Ala Arg Ser Ile Ser Glu 
    50                  55                  60                  


Asp Asp Ser Ala Pro Thr Glu Pro Tyr Pro Gly Pro Glu Gly Pro Arg 
65                  70                  75                  80  


Gln Thr Arg Arg Arg Arg Arg Arg Gln Trp Arg Gln Arg Arg Thr Gln 
                85                  90                  95      


Arg Leu Tyr Leu Gln Gln Arg Ile Phe Glu Ala Ile Phe Gly Ser Arg 
            100                 105                 110         


Thr Ala Ala Leu Glu Asp Ser Leu Gln Gln Leu Gln Ile Ser Asp 
        115                 120                 125         


